HonCode

Go Back   HER2 Support Group Forums > Search Forums
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Showing results 1 to 25 of 500
Search took 0.66 seconds.
Search: Posts Made By: Lani
Forum: her2group 11-14-2020, 09:05 PM
Replies: 0
Views: 441
Posted By Lani
Final Efficacy Results of Neratinib in HER2+ER+ early bc

full text links

https://cdn-ncbi-nlm-nih-gov.laneproxy.stanford.edu/corehtml/query/egifs/tools/DB__1__13__3140.gif (http://sfx.stanford.edu/local?sid=Entrez:PubMed&id=pmid:33183970)

actions...
Forum: her2group 09-23-2020, 09:14 AM
Replies: 0
Views: 397
Posted By Lani
FDA APPROVES 1st PAN-TUMOUR LIQUID BIOPSY TEST FOR PATIENTS WITH ADVAnced CANCER

FDA APPROVES FIRST COMPREHENSIVE PAN-TUMOUR LIQUID BIOPSY TEST FOR PATIENTS WITH ADVANCED CANCER

A qualitative next generation sequencing based in vitro diagnostic test analyzes more than 300...
Forum: her2group 07-18-2020, 09:26 PM
Replies: 1
Views: 785
Posted By Lani
Thumbs up DE-ESCALATING TREATMENT FOR HER2+ early breast cancer

Trans Am Clin Climatol Assocv.131; 2020PMC7358497

Trans Am Clin Climatol Assoc. 2020; 131: 119–126.
PMCID: PMC7358497
PMID: 32675852
DE-ESCALATING TREATMENT FOR HER2-POSITIVE EARLY BREAST...
Forum: her2group 07-18-2020, 08:55 PM
Replies: 0
Views: 576
Posted By Lani
Thumbs up Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2+ Metastatic

Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Tria


J Clin Oncol
. 2020 Jul 17;JCO2000147. doi: 10.1200/JCO.20.00147. Online ahead of print.
Neratinib Plus...
Forum: her2group 07-05-2020, 12:04 PM
Replies: 2
Views: 1,388
Posted By Lani
GREAT NEWS: FDA approves at home submit dual anti-her2/3 therapy

can home hylecta be far behind?


FDA Approves In-home Breast Cancer Treatment

Advantageous for Infusion Centers?

Nick Mulcahy
June 29, 2020
Forum: her2group 06-18-2020, 12:47 PM
Replies: 3
Views: 1,495
Posted By Lani
Thumbs up Tucatinib Is Active Against Brain Metastases in HER2+ Breast Cancer

Research Watch
Tucatinib Is Active Against Brain Metastases in HER2+ Breast Cancer






DOI: 10.1158/2159-8290.CD-RW2020-087
Forum: her2group 05-31-2020, 06:38 PM
Replies: 1
Views: 995
Posted By Lani
Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2+ Brea

Breast Cancer With Brain Metastases in the HER2CLIMB Trial


J Clin Oncol
. 2020 May 29;JCO2000775. doi: 10.1200/JCO.20.00775. Online ahead of print.
Intracranial Efficacy and Survival With...
Forum: her2group 05-01-2020, 10:24 PM
Replies: 1
Views: 963
Posted By Lani
Thumbs up Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus

standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive stage 4 breast cancer



Lancet Oncol. 2020 Apr 27. pii: S1470-2045(20)30112-1. doi:...
Forum: her2group 04-30-2020, 08:00 AM
Replies: 0
Views: 716
Posted By Lani
for those with lepto-meningeal mets

J Neurooncol. 2020 Apr 29. doi: 10.1007/s11060-020-03510-y. [Epub ahead of print]
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP...
Forum: her2group 04-29-2020, 06:59 PM
Replies: 1
Views: 780
Posted By Lani
Re: FDA approves tucatinib for Stage 4 her2+ breast cancer

Cancer
CancerScope Free Access
Addition of tucatinib to trastuzumab and chemotherapy improves survival for patients with metastatic, HER2‐positive breast cancer
Carrie Printz
First published: 28...
Forum: her2group 04-28-2020, 07:59 AM
Replies: 1
Views: 780
Posted By Lani
FDA approves tucatinib for Stage 4 her2+ breast cancer

U.S. Food and Drug Administration FDA approves tucatinib for patients with HER2-positive metastatic breast cancer
FDA approves tucatinib for patients with HER2-positive metastatic breast cancer...
Forum: her2group 03-21-2020, 12:36 PM
Replies: 1
Views: 921
Posted By Lani
any hope of getting insurance companies to cover hylecta in view of covid19 pandemic?

utilizes. less hospital/clinic time, resources AND PERHAPS COULD BE GIVEN BY HOME HEALTH NURSES OR PCP office


thoughts?

Lani
Forum: her2group 01-25-2020, 07:19 PM
Replies: 0
Views: 909
Posted By Lani
Thumbs up mtor inhibitor reverses resistance to neratinib

NEWS RELEASE 23-JAN-2020
Researchers uncover two-drug combo that halts the growth of cancer cells

Discovery could counter resistance to promising new breast cancer therapy
UT SOUTHWESTERN...
Forum: her2group 12-20-2019, 03:55 PM
Replies: 0
Views: 1,072
Posted By Lani
Lightbulb DS8201 accelerated approval by FDA

HEALTH NEWSDECEMBER 20, 2019 / 10:47 PM / UPDATED AN HOUR AGO
AstraZeneca, Daiichi's breast cancer drug gets accelerated approval from FDA
2 MIN READ
FREUTERS/Brendan McDermid
(Reuters) - The...
Forum: her2group 12-11-2019, 06:48 PM
Replies: 0
Views: 822
Posted By Lani
sabcs: Updated APHINITY Supports Benefit of Dual HER2 Blockade

www.medscape.com

Updated APHINITY Supports Benefit of Dual HER2 Blockade
Pam Harrison

December 11, 2019

SAN ANTONIO, Texas — An updated analysis of the APHINITY trial strengthens earlier...
Forum: her2group 12-11-2019, 03:22 PM
Replies: 0
Views: 1,082
Posted By Lani
Thumbs up remarkable new drug for her2+mbc effective after many previous lines of treatment

HEALTH NEWSDECEMBER 11, 2019 / 2:12 PM / UPDATED 9 HOURS AGO
AstraZeneca-Daiichi drug halts cancer for months in first readout

(Reuters) - An experimental cancer drug developed by AstraZeneca and...
Forum: her2group 12-11-2019, 09:51 AM
Replies: 1
Views: 1,001
Posted By Lani
Thumbs up SABCS: Tucatinib 'game changing' vs HER2+ MBC, especially w brain mets

News Release 11-Dec-2019 Tucatinib 'game changing' against HER2+ breast cancer, especially with brain metastases

...
Forum: her2group 12-07-2019, 01:39 PM
Replies: 0
Views: 1,017
Posted By Lani
Outcomes in HR+/HER2+ Metastatic Breast Cancer Pts: A Natnl Cancer Database Analysis

Format: Abstract

Send to
Sci Rep. 2019 Dec 2;9(1):18126. doi: 10.1038/s41598-019-54402-9.
Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National...
Forum: her2group 12-07-2019, 12:54 PM
Replies: 0
Views: 953
Posted By Lani
NSABP FB-7 paclitaxel + herceptin +/_neratinib

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2 + breast cancer | Breast Cancer...
Forum: her2group 09-18-2019, 09:37 AM
Replies: 0
Views: 1,322
Posted By Lani
guide to treatment deescalation: her2 heterogeneity predicts response2 preop tdm1 &

pertuzumab combo


ASCO Reading Room 09.17.2019
HER2 Heterogeneity and Response to Neoadjuvant Therapy
Study confirms lower rates of HER2 expression, pCR in HER2+ breast cancer treated with...
Forum: her2group 09-12-2019, 04:59 PM
Replies: 72
Views: 18,012
Posted By Lani
Re: Whack-a-mole next...

Vantage Logo May 08, 2019
Astra and Daiichi lay out their plan for a better Herceptin


Jacob Plieth
The companies’ DS-8201 succeeds in breast cancer patients who had failed Kadcyla, and...
Forum: her2group 09-10-2019, 09:30 PM
Replies: 3
Views: 1,709
Posted By Lani
Lasker award to Drs Slamon, Ullrich, Shepard

www.medscape.com

Lasker Awards Honor Seminal Advances in Immunology, Breast Cancer
Megan Brooks

September 10, 2019

The 2019 winners of the Lasker Awards were announced today. The awards...
Forum: her2group 09-06-2019, 10:31 AM
Replies: 72
Views: 18,012
Posted By Lani
Re: Whack-a-mole next...new target for "Lazarus effect"--keep up the hope

HEALTH NEWSSEPTEMBER 6, 2019 / 7:58 AM / UPDATED 4 HOURS AGO
Inside drugmakers' strategy to boost cancer medicines with 'Lazarus effect'
Julie Steenhuysen, Ludwig Burger
8 MIN READ
(Reuters) - In...
Forum: her2group 07-08-2019, 01:12 PM
Replies: 0
Views: 1,615
Posted By Lani
Two-in-one drug combining Herceptin with chemotherapy keeps her2+ breast cancers at

27
JUN
2019
Two-in-one drug combining Herceptin with chemotherapy keeps women’s breast cancers at bay
Like on Facebook Tweet on Twitter Share on Google Plus Share on LinkedIn
False-coloured...
Forum: her2group 07-05-2019, 09:45 AM
Replies: 0
Views: 1,371
Posted By Lani
Thumbs up determining which her2+ bc patients can forgo chemo, where dual anti-her2 treatment

suffices

Friday, July 5, 2019

PROGRESS NOTES
BCM.EDU
From The Labs
De-escalating breast cancer therapy; can some patients be spared chemotherapy?
June 25, 2019 Breast Cancer,...
Showing results 1 to 25 of 500

 
Forum Jump

All times are GMT -7. The time now is 03:54 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2021, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter